Valuation check: CNVIF's profit margin is -531.26%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2024
Trailing 12 months ending Jun 2024
Conavi Medical (CNVIF) currently reports a profit margin of -531.26% as of June 2024. That compares with -70.7% in the prior-year period — down 651.4% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Conavi Medical's profit margin history and peer comparisons.
Conavi Medical's profit margin decreased from -70.7% to -531.26% — a 651.4% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Conavi Medical's profit margin of -531.26% is lower than the Healthcare sector average of 19.13%. That is roughly 2876.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Conavi Medical's current -531.26% should be judged against Healthcare norms (sector average: 19.13%) and against CNVIF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -531.26%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Conavi Medical, and consider following CNVIF for alerts when major investors trade the stock.